Perampanel for the control of glioma associated seizures efficacy and safety: a pilot phase II randomised controlled trial
Phase of Trial: Phase II
Latest Information Update: 20 Jul 2017
At a glance
- Drugs Perampanel (Primary) ; Levetiracetam
- Indications Epilepsy; Glioma
- Focus Therapeutic Use
- Acronyms PEGASUS-1
- 19 Jul 2017 Status changed from not yet recruiting to recruiting.
- 08 Jun 2017 Planned End Date changed from 31 Oct 2019 to 31 Mar 2020.
- 08 Jun 2017 Planned initiation date changed from 28 Feb 2017 to 12 Jul 2017.